Insulet Corporation (NASDAQ:PODD) ranks among the best medical device stocks to invest in. Canaccord Genuity maintained its Buy rating on Insulet Corporation (NASDAQ:PODD) and boosted its price target ...
Hosted on MSN
Stifel Reiterates Insulet (PODD) Buy Recommendation
Fintel reports that on October 21, 2025, Stifel reiterated coverage of Insulet (NasdaqGS:PODD) with a Buy recommendation. Analyst Price Forecast Suggests 11.72% Upside As of September 29, 2025, the ...
Insulet Corporation (NASDAQ:PODD) is one of the best NASDAQ growth stocks to buy for the next 5 years. On October 10, RBC Capital raised the price target on Insulet to $365 from $350 and kept an ...
Anil R. Diwan, PhD, President and Executive Chairman of the Company will provide an update on the Company, its Drug Pipeline and Platform Technologies available for licensing. NanoViricides’ Current ...
Saber Interactive, the developers behind 2024’s hit, Space Marine 2, have some good news to share. Warhammer 40,000: Space Marine 2 is offering a time-limited free demo from October 16 to October 23 ...
Helsinki, Finland – October 21, 2025 - Nanoform Finland Plc (“Nanoform”), a leading nanoparticle medicine performance-enhancing company, today announced that key findings from two proof-of-concept ...
Enjoy Studio has announced that it will be releasing the Everwind demo slightly earlier than planned, with those interested in the game able to try it out from tomorrow, October 12th. The demo will ...
PharmaJet will deliver two presentations on October 27 focusing on current and future applications of their needle-free technology. The Tropis ® intradermal (ID) Needle-free Injection System overcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback